Clinical Trial Update: Utility of CAML as Diagnostic for Early Stage Lung Cancer

View source ↗

Summary

The clinical trial evaluating CAML as a diagnostic for early-stage lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Pulmonary Nodule, Multiple, Pulmonary Nodule, Solitary | Status: TERMINATED